Mercer Global Advisors’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Mercer Global Advisors’s Portfolio QNTM Stock Details QNTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$688	Buy	+190	New	+$897	﹤0.01%	5785

Other funds holding QNTM

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

PTP

Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $6.54B AUM

AUB

Atlantic Union Bankshares Glen Allen, Virginia $5.99B AUM 23.66% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mercer Global Advisors's QNTM Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q2 2026: 190 shares worth $688. The stake represents ﹤0.01% of the portfolio and ranks #5785 among its holdings.

18 funds tracked by Wall St. Rank hold QNTM as of Q2 2026.

Mercer Global Advisors held 190 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $688 as of Q2 2026.
Quantum Biopharma Class B Subordinate Voting Shares was a new Mercer Global Advisors position in Q2 2026.
Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5785 holding.
18 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.